LU67790A1 - - Google Patents
Info
- Publication number
- LU67790A1 LU67790A1 LU67790A LU67790DA LU67790A1 LU 67790 A1 LU67790 A1 LU 67790A1 LU 67790 A LU67790 A LU 67790A LU 67790D A LU67790D A LU 67790DA LU 67790 A1 LU67790 A1 LU 67790A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2811872A GB1434919A (en) | 1972-06-15 | 1972-06-15 | 3alpha-hydroxy androstanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU67790A1 true LU67790A1 (en:Method) | 1973-08-16 |
Family
ID=10270562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU67790A LU67790A1 (en:Method) | 1972-06-15 | 1973-06-14 |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800899R (en:Method) |
| CA (1) | CA1040619A (en:Method) |
| DE (1) | DE2330342A1 (en:Method) |
| DK (1) | DK136157B (en:Method) |
| FR (1) | FR2189034B2 (en:Method) |
| GB (1) | GB1434919A (en:Method) |
| LU (1) | LU67790A1 (en:Method) |
| NL (1) | NL7308267A (en:Method) |
| ZA (1) | ZA734037B (en:Method) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019126333A (ru) | 2013-04-17 | 2019-10-08 | Сейдж Терапьютикс, Инк. | 19-нор нейроактивные стероиды и способы их применения |
| CN113527400B (zh) | 2013-04-17 | 2024-06-28 | 萨奇治疗股份有限公司 | 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法 |
| US20160068563A1 (en) | 2013-04-17 | 2016-03-10 | Boyd L. Harrison | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| WO2015010054A2 (en) * | 2013-07-19 | 2015-01-22 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| AU2014308621C1 (en) | 2013-08-23 | 2022-01-06 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| MX2021004492A (es) | 2014-10-16 | 2022-12-05 | Sage Therapeutics Inc | Composiciones para el tratamiento de trastornos del snc. |
| SMT202000414T1 (it) | 2014-10-16 | 2020-09-10 | Sage Therapeutics Inc | Composizioni e metodi per trattare disturbi del snc |
| ME03749B (me) | 2014-11-27 | 2021-04-20 | Sage Therapeutics Inc | KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a |
| DK3250210T3 (da) | 2015-01-26 | 2021-03-08 | Sage Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| CA3030420C (en) | 2016-07-11 | 2025-11-18 | Sage Therapeutics, Inc. | C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE |
| CN114206900A (zh) | 2019-05-31 | 2022-03-18 | 萨奇治疗股份有限公司 | 神经活性类固醇及其组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| DE2162555A1 (de) * | 1970-12-17 | 1972-06-22 | Glaxo Laboratories Ltd., Greenford, Middlesex (Grossbritannien) | Anästhetisch wirkende Steroidverbindungen |
| GB1380246A (en) * | 1970-12-17 | 1975-01-08 | Glaxo Lab Ltd | 3alpha-hydroxy-androstanes and esters thereof |
-
1972
- 1972-06-15 GB GB2811872A patent/GB1434919A/en not_active Expired
-
1973
- 1973-06-14 LU LU67790A patent/LU67790A1/xx unknown
- 1973-06-14 DK DK328673AA patent/DK136157B/da unknown
- 1973-06-14 ZA ZA734037A patent/ZA734037B/xx unknown
- 1973-06-14 NL NL7308267A patent/NL7308267A/xx not_active Application Discontinuation
- 1973-06-14 DE DE2330342A patent/DE2330342A1/de not_active Ceased
- 1973-06-14 BE BE132254A patent/BE800899R/xx active
- 1973-06-14 CA CA174,050A patent/CA1040619A/en not_active Expired
- 1973-06-14 FR FR7321743A patent/FR2189034B2/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7308267A (en:Method) | 1973-12-18 |
| DK136157B (da) | 1977-08-22 |
| AU5693773A (en) | 1974-12-19 |
| DK136157C (en:Method) | 1978-01-23 |
| GB1434919A (en) | 1976-05-12 |
| FR2189034B2 (en:Method) | 1977-01-21 |
| BE800899R (fr) | 1973-12-14 |
| DE2330342A1 (de) | 1974-01-17 |
| ZA734037B (en) | 1974-05-29 |
| FR2189034A2 (en:Method) | 1974-01-25 |
| CA1040619A (en) | 1978-10-17 |